Guifang Jia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guifang Jia has a total of 249 co-authors. Here are the top co-authors by number of shared publications:
- Baojun Chen
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Laboratory Animal, Peking University Cancer Hospital and Institute, Beijing, China
14 shared publications - Chang Zhang
Peking University Shougang Hospital 6 Department of Pathology Beijing, China
14 shared publications - Dengbo Ji
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery III, Peking University Cancer Hospital & Institute, Beijing, China
14 shared publications - Haopeng Hong
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Surgery III, Peking University Cancer Hospital and Institute, Beijing, China
14 shared publications - Jin Gu
Department of Gastrointestinal Surgery, Peking University Shougang Hospital, Beijing, China
14 shared publications - Jingxuan Xu
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Surgery III, Peking University Cancer Hospital and Institute, Beijing, China
14 shared publications
Latest Publications
- 25 August 2026
- Published by Elsevier in Molecular Plant
- Vol. 19 (11) , 2145-2148
Plant m6A writers, erasers, and readers
- 25 August 2026
- Published by Elsevier in Molecular Plant
- Vol. 19 (11) , 2145-2148
Plant m6A writers, erasers, and readers
- 8 July 2026
- Published by Elsevier in Developmental Cell
- Vol. 61 (7) , 1446-1470
Noncanonical caps, m6A, and Ψ RNA modifications in plant and animal development
- 8 July 2026
- Published by Elsevier in Developmental Cell
- Vol. 61 (7) , 1446-1470
Noncanonical caps, m6A, and Ψ RNA modifications in plant and animal development
- 26 June 2026
- Published by Springer Nature in Science China Life Sciences
- p. 1-45
RNA regulation in plants
Eukaryotic genomes are pervasively transcribed, producing a vast repertoire of RNA molecules. In plants, diverse RNA species play pivotal roles in regulating growth, development, and responses to environmental stimuli. The activities of RNAs are determined not only by their nucleotide sequences but are also shaped by multiple regulatory mechanisms, including processing, turnover, chemical modifications, and higher-order structure formation—each contributing critically to phenotypic outcomes. Over the past decade, technological advances, particularly in high-throughput sequencing and genome editing, have substantially deepened our understanding of RNA regulation; concurrently, research in this field has expanded from foundational studies in Arabidopsis to encompass a broad range of crop species. Building upon this expanded knowledge, this review provides a comprehensive overview of the regulation and functions of RNAs in plants. Specifically, we discuss the roles and molecular mechanisms of diverse RNA types, the roles of RNA structures and modifications in regulatory processes, and the translational application of RNA-based strategies for improving agronomic traits. Finally, we outline future research directions and offer perspectives on harnessing RNA regulation to advance crop improvement.
- 26 June 2026
- Published by Springer Nature in Science China Life Sciences
- p. 1-45
RNA regulation in plants
Eukaryotic genomes are pervasively transcribed, producing a vast repertoire of RNA molecules. In plants, diverse RNA species play pivotal roles in regulating growth, development, and responses to environmental stimuli. The activities of RNAs are determined not only by their nucleotide sequences but are also shaped by multiple regulatory mechanisms, including processing, turnover, chemical modifications, and higher-order structure formation—each contributing critically to phenotypic outcomes. Over the past decade, technological advances, particularly in high-throughput sequencing and genome editing, have substantially deepened our understanding of RNA regulation; concurrently, research in this field has expanded from foundational studies in Arabidopsis to encompass a broad range of crop species. Building upon this expanded knowledge, this review provides a comprehensive overview of the regulation and functions of RNAs in plants. Specifically, we discuss the roles and molecular mechanisms of diverse RNA types, the roles of RNA structures and modifications in regulatory processes, and the translational application of RNA-based strategies for improving agronomic traits. Finally, we outline future research directions and offer perspectives on harnessing RNA regulation to advance crop improvement.
- Open Access
- 22 June 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (12)
VeloRM: disentangling pre- and post-splicing RNA modification dynamics at single-cell resolution
RNA modifications critically regulate RNA function and fate, yet their dynamic changes across the RNA life cycle and during cellular transitions remain largely unexplored. Here we introduce VeloRM, a computational framework that captures RNA modification dynamics at single-cell resolution. VeloRM uniquely disentangles presplicing and postsplicing epitranscriptomes, enabling for the first time the identification and differentiation of modification sites on transcripts before versus after splicing. By modeling the velocity of epitranscriptomic changes, VeloRM predicts future RNA modification states and reconstructs cellular trajectories directly from epitranscriptome information. Application to single-cell datasets profiling m6A and A-to-I editing demonstrates that VeloRM accurately recapitulates known trajectory patterns in cell cycle and differentiation. Notably, VeloRM reveals for the first time a set of m6A sites that are hyper-methylated on prespliced RNAs near splice junctions, with dynamic patterns that unveil clear functional implications in splicing regulation. VeloRM represents a rigorous yet powerful tool that opens unprecedented opportunities to study epitranscriptome dynamics during biological transitions.
- 22 June 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (12)
Open AccessVeloRM: disentangling pre- and post-splicing RNA modification dynamics at single-cell resolution
RNA modifications critically regulate RNA function and fate, yet their dynamic changes across the RNA life cycle and during cellular transitions remain largely unexplored. Here we introduce VeloRM, a computational framework that captures RNA modification dynamics at single-cell resolution. VeloRM uniquely disentangles presplicing and postsplicing epitranscriptomes, enabling for the first time the identification and differentiation of modification sites on transcripts before versus after splicing. By modeling the velocity of epitranscriptomic changes, VeloRM predicts future RNA modification states and reconstructs cellular trajectories directly from epitranscriptome information. Application to single-cell datasets profiling m6A and A-to-I editing demonstrates that VeloRM accurately recapitulates known trajectory patterns in cell cycle and differentiation. Notably, VeloRM reveals for the first time a set of m6A sites that are hyper-methylated on prespliced RNAs near splice junctions, with dynamic patterns that unveil clear functional implications in splicing regulation. VeloRM represents a rigorous yet powerful tool that opens unprecedented opportunities to study epitranscriptome dynamics during biological transitions.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
Validation that AKT3 overexpression enhances the invasion and migration capabilities of colorectal cancer cells.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
Validation that AKT3 overexpression enhances the invasion and migration capabilities of colorectal cancer cells.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Data from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
Colorectal ovarian metastasis (CROM), a distinct metastatic subtype of colorectal cancer, is associated with early disease onset and aggressive progression. CROM lacks specific treatment options, highlighting the need to elucidate the underlying biological mechanisms and potential therapeutic vulnerabilities. In this study, we performed integrated analyses of single-cell RNA sequencing (scRNA-seq) datasets from 155,163 cells across 35 patients from the in-house cohort and public datasets, with matched bulk transcriptomic profiling. The analysis identified AKT3+ epithelial–mesenchymal transition (EMT)-like cells at the invasive tumor–stroma interface as metastasis-initiating cells. Functional validation using in vivo xenograft models demonstrated that AKT3 deficiency reduced ovarian colonization, whereas AKT3 overexpression conferred a mesenchymal phenotype with invasive capacity. Furthermore, reciprocal cross-talk between AKT3+ mesenchymal-like cells and cancer-associated fibroblasts (CAF) played a key role in remodeling the tumor microenvironment. Multiplex immunofluorescence staining of primary tumor specimens revealed spatially coordinated AKT3+/SNAIL+/ITGB1+ tumor buds adjacent to αSMA+ CAFs at the invasive front. Critically, AKT3 inhibition or knockdown in patient-derived CROM organoids (CROM-PDO) significantly suppressed malignant phenotypes, recapitulating the AKT3 dependency. Collectively, these findings elucidate an AKT3-driven feedforward loop coupling EMT plasticity with CAF activation as a critical driver of CROM and propose CROM-PDOs as a robust platform for developing precision therapies targeting this aggressive colorectal cancer subtype.Significance:Single-cell analyses reveal AKT3-expressing mesenchymal-like cells as drivers of colorectal ovarian metastases, which depends on the dynamic cross-talk between cancer cells and cancer-associated fibroblasts within the immunosuppressive ovarian niche.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
Colorectal ovarian metastasis (CROM), a distinct metastatic subtype of colorectal cancer, is associated with early disease onset and aggressive progression. CROM lacks specific treatment options, highlighting the need to elucidate the underlying biological mechanisms and potential therapeutic vulnerabilities. In this study, we performed integrated analyses of single-cell RNA sequencing (scRNA-seq) datasets from 155,163 cells across 35 patients from the in-house cohort and public datasets, with matched bulk transcriptomic profiling. The analysis identified AKT3+ epithelial–mesenchymal transition (EMT)-like cells at the invasive tumor–stroma interface as metastasis-initiating cells. Functional validation using in vivo xenograft models demonstrated that AKT3 deficiency reduced ovarian colonization, whereas AKT3 overexpression conferred a mesenchymal phenotype with invasive capacity. Furthermore, reciprocal cross-talk between AKT3+ mesenchymal-like cells and cancer-associated fibroblasts (CAF) played a key role in remodeling the tumor microenvironment. Multiplex immunofluorescence staining of primary tumor specimens revealed spatially coordinated AKT3+/SNAIL+/ITGB1+ tumor buds adjacent to αSMA+ CAFs at the invasive front. Critically, AKT3 inhibition or knockdown in patient-derived CROM organoids (CROM-PDO) significantly suppressed malignant phenotypes, recapitulating the AKT3 dependency. Collectively, these findings elucidate an AKT3-driven feedforward loop coupling EMT plasticity with CAF activation as a critical driver of CROM and propose CROM-PDOs as a robust platform for developing precision therapies targeting this aggressive colorectal cancer subtype.Significance:Single-cell analyses reveal AKT3-expressing mesenchymal-like cells as drivers of colorectal ovarian metastases, which depends on the dynamic cross-talk between cancer cells and cancer-associated fibroblasts within the immunosuppressive ovarian niche.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
ScRNA-seq quality control metrics and cell type distribution in colorectal ovarian metastasis (CROM) samples.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
ScRNA-seq quality control metrics and cell type distribution in colorectal ovarian metastasis (CROM) samples.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
The inhibitory effect of the AKT inhibitor Uprosertib on the proliferation and migration of CRC cell lines (HT29 and SW480).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
The inhibitory effect of the AKT inhibitor Uprosertib on the proliferation and migration of CRC cell lines (HT29 and SW480).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
Pathway enrichment analysis and validation of AKT3, SNAIL, and CDH2 expression in CROM patient samples and organoids.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from AKT3-Driven Epithelial–Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling
Pathway enrichment analysis and validation of AKT3, SNAIL, and CDH2 expression in CROM patient samples and organoids.